
    
      The clinical trial is a randomized, controlled, three-arm, double-blind study, involving up
      to 120 patients. Eligible subjects will be randomly allocated to one of the three treatment
      groups: control group, treated with core decompression technique, study group 1, treated with
      subchondral plasty by injecting i-FactorTM, and study group 2, treated by injections of
      autologous BMC.
    
  